Evidence map›Paper›PMID 32676116›Full record

ArticleInternational journal of microbiology2020

Antibacterial Potential of Secondary Metabolites from Indonesian Marine Bacterial Symbionts.

Risa Nofiani, Alexandra J Weisberg, Takeshi Tsunoda, Ruqiah Ganda Putri Panjaitan, Ridho Brilliantoro, Jeff H Chang, Benjamin Philmus, Taifo Mahmud

Abstract read
In one paragraph

Article in International journal of microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Biodiversity and Natural Product Potential of Indonesian Actinomycetes.Journal of microbiology and biotechnology · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Risa NofianiDepartment of Chemistry, University of Tanjungpura, Pontianak 78124, Indonesia.ORCID https://orcid.org/0000-0003-1031-2318
Alexandra J WeisbergDepartment of Botany and Plant Pathology, Oregon State University, Corvallis, OR 97331, USA.
Takeshi TsunodaDepartment of Pharmaceutical Sciences, Oregon State University, Corvallis, OR 97331, USA.
Ruqiah Ganda Putri PanjaitanDepartment of Biological Education, University of Tanjungpura, Pontianak 78124, Indonesia.
Ridho BrilliantoroDepartment of Chemistry, University of Tanjungpura, Pontianak 78124, Indonesia.
Jeff H ChangDepartment of Botany and Plant Pathology, Oregon State University, Corvallis, OR 97331, USA.
Benjamin PhilmusDepartment of Pharmaceutical Sciences, Oregon State University, Corvallis, OR 97331, USA.
Taifo MahmudDepartment of Pharmaceutical Sciences, Oregon State University, Corvallis, OR 97331, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Indonesian marine environments are known to house diverse organisms. However, the potential for bacteria from these environments as a source of antibacterial agents has not been widely studied. This study aims to explore the antibacterial potential of secondary metabolites produced by bacterial symbionts from sponges and corals collected in the Indonesian waters. Extracts of 12 bacterial isolates from sponges or corals were prepared by cultivating the bacteria under a number of different media conditions and using agar well diffusion assays to test for antibacterial activity. In addition, the morphology, physiology, and biochemical characteristics and 16S rRNA sequence of each isolate were used to determine their taxonomic classification. All tested bacterial isolates were able to produce secondary metabolites with various levels of antibacterial activity depending on medium composition and culture conditions. Two of the bacteria (RS3 and RC4) showed strong antibacterial activities against both Gram-negative and Gram-positive bacteria. A number of isolates (RS1, RS3, and RC2) were co-cultured with mycolic acid-containing bacteria,

Identifiers

PMID32676116
PMCPMC7341410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.